Market Tracker

07/24 8:33am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

3.43
Delayed Data
As of Jul 21
 -1.06 / -23.61%
Today’s Change
1.83
Today|||52-Week Range
10.40
+76.80%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close4.49
Today’s open4.54
Day’s range3.43 - 4.54
Volume1,255,636
Average volume (3 months)369,078
Market cap$34.4M
Dividend yield--
Data as of 07/21/2017

Growth & Valuation

Earnings growth (last year)+22.05%
Earnings growth (this year)+25.93%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)-19.90%
P/E ratioNM
Price/Sales0.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...-0.19-0.87%
CHMAChiasma Inc-0.02-1.72%
MBRXMoleculin Biotech In...+0.01+0.53%
THLDThreshold Pharmaceut...-0.00-0.90%
Data as of 07/21/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)-$4.40
Annual revenue (last year)$140.9M
Annual profit (last year)-$169.6M
Net profit margin-120.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts